Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer

Eitemau Tebyg

• Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
  gan: Michael D. Nyquist (16918265)
  Cyhoeddwyd: (2025)
• Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
  gan: Michael D. Nyquist (16918265)
  Cyhoeddwyd: (2025)
• Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
  gan: Milana A. Bergamino (15038015)
  Cyhoeddwyd: (2025)
• Figure 2 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
  gan: Milana A. Bergamino (15038015)
  Cyhoeddwyd: (2025)
• Figure 3 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
  gan: Milana A. Bergamino (15038015)
  Cyhoeddwyd: (2025)